Published in

BioMed Central, BMC Medicine, 1(13), 2015

DOI: 10.1186/s12916-015-0526-x

Links

Tools

Export citation

Search in Google Scholar

Who and when should we screen for prostate cancer? Interviews with key opinion leaders

Journal article published in 2015 by Sigrid Carlsson ORCID, Michael Leapman, Peter Carroll, Fritz Schröder, Peter C. Albertsen, Dragan Ilic ORCID, Michael Barry, Dominick L. Frosch, Andrew Vickers ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Prostate cancer screening using prostate-specific antigen (PSA) is highly controversial. In this Q & A, Guest Editors for BMC Medicine's 'Spotlight on Prostate Cancer' article collection, Sigrid Carlsson and Andrew Vickers, invite some of the world's key opinion leaders to discuss who, and when, to screen for prostate cancer. In response to the points of view from the invited experts, the Guest Editors summarize the experts' views and give their own personal opinions on PSA screening.